CWIAX
Price
$82.67
Change
+$0.67 (+0.82%)
Updated
Aug 21 closing price
Net Assets
155.99B
ECDIX
Price
$22.18
Change
+$0.15 (+0.68%)
Updated
Aug 21 closing price
Net Assets
846.21M
Interact to see
Advertisement

CWIAX vs ECDIX

CWIAX vs ECDIX Comparison Chart in %
View a ticker or compare two or three
VS
CWIAX vs. ECDIX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWIAX is a StrongBuy and ECDIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CWIAX has more cash in the bank: 156B vs. ECDIX (846M). ECDIX pays higher dividends than CWIAX: ECDIX (2.67) vs CWIAX (1.35). CWIAX was incepted earlier than ECDIX: CWIAX (25 years) vs ECDIX (23 years). ECDIX (1.92) is less costly to investors than CWIAX (0.75). ECDIX is a more actively managed with annual turnover of: 102.00 vs. CWIAX (44.00). CWIAX has a lower initial minimum investment than ECDIX: CWIAX (250) vs ECDIX (1000). ECDIX annual gain was more profitable for investors over the last year : 26.04 vs. CWIAX (17.18). ECDIX return over 5 years is better than : 46.69 vs. CWIAX (39.81).
CWIAXECDIXCWIAX / ECDIX
Total Expense Ratio0.751.9239%
Annual Report Gross Expense Ratio0.751.9239%
Fund Existence25 years23 years-
Gain YTD17.02814.250119%
Front Load4%N/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets156B846M18,440%
Annual Yield % from dividends1.352.6751%
Returns for 1 year17.1826.0466%
Returns for 3 years54.7565.2784%
Returns for 5 years39.8146.6985%
Returns for 10 years115.53132.5687%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MAPPX25.860.56
+2.21%
Morgan Stanley Inst Advantage A
NMANX15.300.16
+1.06%
Neuberger Mid Cap Growth Inv
HSMBX47.180.38
+0.81%
Horizon Multi-Factor Small/Mid Cap Adv
JVACX42.180.22
+0.52%
JPMorgan Value Advantage C
RYMGX62.120.31
+0.50%
Rydex S&P MidCap 400 Pure Growth A